XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2024
Jan. 31, 2023
Cash flows from operating activities:        
Net loss $ (6,509,000) $ (6,090,000) $ (20,761,000) $ (16,786,000)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation of fixed assets 114,000 40,000 286,000 157,000
Foreign exchange gain     2,000
Amortization of intangible assets 34,000 40,000 114,000 119,000
Amortization of right of use assets     388,000 230,000
(Accretion of discount)/amortization of premium on investments     (277,000) 198,000
Change in contingent consideration liability (33,000) 373,000 (117,000) 154,000
Stock based compensation 100,000 300,000 803,000 911,000
Loss on disposition of assets 210,000 210,000
Changes in operating assets and liabilities:        
Accounts receivable     120,000 (224,000)
Contract assets     (129,000) 293,000
Inventory     (2,416,000) (995,000)
Other assets     (2,933,000) (1,530,000)
Accounts payable     512,000 (314,000)
Earnout payable     (500,000)
Accrued expenses     894,000 747,000
Right-of-use liabilities     (397,000) (254,000)
Contract liabilities     (510,000) 1,205,000
Net cash used in operating activities     (24,711,000) (16,089,000)
Cash flows from investing activities:        
Redemptions of short term investments     31,625,000 49,584,000
Purchases of short term investments     (7,935,000) (30,402,000)
Purchases of property and equipment     (1,224,000) (302,000)
Net cash provided by investing activities     22,466,000 18,880,000
Cash flows from financing activities:        
Cash paid for tax withholding related to shares withheld     (13,000) (14,000)
Proceeds from issuance of common stock - Cantor At The Market offering, net of issuance costs     29,000
Net cash provided by/(used in) financing activities     16,000 (14,000)
Net (decrease) / increase in cash, cash equivalents and restricted cash     (2,229,000) 2,777,000
Cash, cash equivalents and restricted cash, beginning of period     7,103,000 8,362,000
Cash, cash equivalents and restricted cash, end of period $ 4,874,000 $ 11,139,000 4,874,000 11,139,000
Supplemental disclosure of noncash investing and financing activities:        
Common stock issued related to bonus and earnout payments     1,250,000
Operating right of use asset obtained in exchange for operating lease liability     $ 1,247,000